Literature DB >> 8039897

Immunogenicity of the Plasmodium falciparum glutamate-rich protein expressed by vaccinia virus.

M Theisen1, G Cox, B Høgh, S Jepsen, J Vuust.   

Abstract

The glurp gene of Plasmodium falciparum F32 has been inserted into a vaccinia virus, and the recombinant virus was designated VVG4. Expression of glurp in VVG4-infected Vero cells was analyzed by immunoprecipitation and revealed a primary GLURP product of approximately 220,000 Da; GLURP was detected both intracellularly and in culture supernatants. To study the immunogenicity of vaccinia virus-expressed GLURP, mice were immunized with VVG4 and serum samples were analyzed for antibody reactivity with three polypeptides, covering almost the entire GLURP molecule; these three polypeptides were produced in recombinant form in Escherichia coli. The immune response was primarily directed against a carboxy-terminal repeat region. The mouse anti-GLURP serum recognized authentic GLURP by immunoprecipitation analysis from P. falciparum grown in vitro. These results demonstrate that vaccinia virus-expressed glurp product can induce a humoral immune response against GLURP derived from blood-stage parasites.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8039897      PMCID： PMC302955          DOI： 10.1128/iai.62.8.3270-3275.1994

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  19 in total

1.  Class II restriction in mice to the malaria candidate vaccine ring infected erythrocyte surface antigen (RESA) as synthetic peptides or as expressed in recombinant vaccinia.

Authors:  A M Lew; C J Langford; D Pye; S Edwards; L Corcoran; R F Anders
Journal:  J Immunol       Date:  1989-06-01       Impact factor: 5.422

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Antibodies to a recombinant glutamate-rich Plasmodium falciparum protein: evidence for protection of individuals living in a holoendemic area of Liberia.

Authors:  B Hogh; E Petersen; M Dziegiel; K David; A Hanson; M Borre; A Holm; J Vuust; S Jepsen
Journal:  Am J Trop Med Hyg       Date:  1992-03       Impact factor: 2.345

4.  Comparison of antibody avidity and titre elicited by peptide as a protein conjugate or as expressed in vaccinia.

Authors:  A M Lew; R F Anders; S J Edwards; C J Langford
Journal:  Immunology       Date:  1988-10       Impact factor: 7.397

5.  Failure of recombinant vaccinia viruses expressing Plasmodium falciparum antigens to protect Saimiri monkeys against malaria.

Authors:  D Pye; S J Edwards; R F Anders; C M O'Brien; P Franchina; L N Corcoran; C Monger; M G Peterson; K L Vandenberg; J A Smythe
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

6.  Single-step purification of bacterially expressed polypeptides containing an oligo-histidine domain.

Authors:  M W Van Dyke; M Sirito; M Sawadogo
Journal:  Gene       Date:  1992-02-01       Impact factor: 3.688

7.  Induction of Plasmodium falciparum transmission-blocking antibodies by recombinant vaccinia virus.

Authors:  D C Kaslow; S N Isaacs; I A Quakyi; R W Gwadz; B Moss; D B Keister
Journal:  Science       Date:  1991-05-31       Impact factor: 47.728

8.  Studies using a recombinant vaccinia virus expressing the circumsporozoite protein of Plasmodium berghei.

Authors:  V Satchidanandam; F Zavala; B Moss
Journal:  Mol Biochem Parasitol       Date:  1991-09       Impact factor: 1.759

9.  Capture ELISA for IgM antibodies against Plasmodium falciparum glutamate rich protein.

Authors:  M Dziegiel; M B Borre; E Petersen; B Högh; S Jepsen; J Vuust; N Axelsen
Journal:  J Immunol Methods       Date:  1992-11-05       Impact factor: 2.303

10.  Immunoglobulin M and G antibody responses to Plasmodium falciparum glutamate-rich protein: correlation with clinical immunity in Gambian children.

Authors:  M Dziegiel; P Rowe; S Bennett; S J Allen; O Olerup; A Gottschau; M Borre; E M Riley
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441
View more
  11 in total

1.  Molecular cloning and characterization of nlpH, encoding a novel, surface-exposed, polymorphic, plasmid-encoded 33-kilodalton lipoprotein of Borrelia afzelii.

Authors:  M Theisen
Journal:  J Bacteriol       Date:  1996-11       Impact factor: 3.490

2.  The glutamate-rich protein (GLURP) of Plasmodium falciparum is a target for antibody-dependent monocyte-mediated inhibition of parasite growth in vitro.

Authors:  M Theisen; S Soe; C Oeuvray; A W Thomas; J Vuust; S Danielsen; S Jepsen; P Druilhe
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

3.  High-density Peptide Arrays Help to Identify Linear Immunogenic B-cell Epitopes in Individuals Naturally Exposed to Malaria Infection.

Authors:  Thomas Jaenisch; Kirsten Heiss; Nico Fischer; Carolin Geiger; F Ralf Bischoff; Gerhard Moldenhauer; Leszek Rychlewski; Ali Sié; Boubacar Coulibaly; Peter H Seeberger; Lucjan S Wyrwicz; Frank Breitling; Felix F Loeffler
Journal:  Mol Cell Proteomics       Date:  2019-01-10       Impact factor: 5.911

4.  Selection of glutamate-rich protein long synthetic peptides for vaccine development: antigenicity and relationship with clinical protection and immunogenicity.

Authors:  M Theisen; D Dodoo; A Toure-Balde; S Soe; G Corradin; K K Koram; J A Kurtzhals; L Hviid; T Theander; B Akanmori; M Ndiaye; P Druilhe
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

5.  Antigenicity and immunogenicity of recombinant glutamate-rich protein of Plasmodium falciparum expressed in Escherichia coli.

Authors:  M Theisen; J Vuust; A Gottschau; S Jepsen; B Høgh
Journal:  Clin Diagn Lab Immunol       Date:  1995-01

Review 6.  The evolution of poxvirus vaccines.

Authors:  Lucas Sánchez-Sampedro; Beatriz Perdiguero; Ernesto Mejías-Pérez; Juan García-Arriaza; Mauro Di Pilato; Mariano Esteban
Journal:  Viruses       Date:  2015-04-07       Impact factor: 5.048

7.  Size and sequence polymorphisms in the glutamate-rich protein gene of the human malaria parasite Plasmodium falciparum in Thailand.

Authors:  Sittiporn Pattaradilokrat; Chawinya Trakoolsoontorn; Phumin Simpalipan; Natapot Warrit; Morakot Kaewthamasorn; Pongchai Harnyuttanakorn
Journal:  Parasit Vectors       Date:  2018-01-22       Impact factor: 3.876

8.  SURGE complex of Plasmodium falciparum in the rhoptry-neck (SURFIN4.2-RON4-GLURP) contributes to merozoite invasion.

Authors:  Maria Del Pilar Quintana; Jun-Hong Ch'ng; Arash Zandian; Maryam Imam; Kjell Hultenby; Michael Theisen; Peter Nilsson; Ulrika Qundos; Kirsten Moll; Sherwin Chan; Mats Wahlgren
Journal:  PLoS One       Date:  2018-08-09       Impact factor: 3.240

9.  Pfs230 and Pfs48/45 Fusion Proteins Elicit Strong Transmission-Blocking Antibody Responses Against Plasmodium falciparum.

Authors:  Susheel K Singh; Susan Thrane; Bishwanath K Chourasia; Karina Teelen; Wouter Graumans; Rianne Stoter; Geert-Jan van Gemert; Marga G van de Vegte-Bolmer; Morten A Nielsen; Ali Salanti; Adam F Sander; Robert W Sauerwein; Matthijs M Jore; Michael Theisen
Journal:  Front Immunol       Date:  2019-06-05       Impact factor: 7.561

10.  Cationic liposomes formulated with synthetic mycobacterial cordfactor (CAF01): a versatile adjuvant for vaccines with different immunological requirements.

Authors:  Else Marie Agger; Ida Rosenkrands; Jon Hansen; Karima Brahimi; Brian S Vandahl; Claus Aagaard; Kerstin Werninghaus; Carsten Kirschning; Roland Lang; Dennis Christensen; Michael Theisen; Frank Follmann; Peter Andersen
Journal:  PLoS One       Date:  2008-09-08       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.